Baxter International, Inc.

Did You Lose Money in Baxter International, Inc. (NYSE: BAX) Stock?

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International, Inc.  (“Baxter” or the “Company”) for alleged violations of federal securities laws. The firm reminds investors that they have until December 15, 2025 to seek appointment as lead plaintiff in the class action filed against the Company.

The complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose: (a) the Novum LVP suffered systemic defects that caused widespread malfunctions, including underinfusion, overinfusion, and complete non-delivery of fluids, which exposed patients to risks of serious injury or death; (b) Baxter was notified of multiple device malfunctions, injuries, and deaths from these defects; (c) Baxter’s attempts to address these defects through customer alerts were inadequate remedial measures, when design flaws persisted and continued to cause serious harm to patients; (d) as a result, there was a heightened risk that customers would be instructed to take existing Novum LVPs out of service and that Baxter would completely pause all new sales of these pumps; and (e) based on the foregoing, Baxter’s statements about the safety, efficacy, product rollout, customer feedback and sales prospects of the Novum LVPs were materially false and misleading.

If you purchased BAX securities between February 23, 2022 and July 30, 2025 , you may be eligible to recover your losses.
Lead Plaintiff Deadline: December 15, 2025